References
- Faustini A, Hall AJ, Perucci CA. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax 2006;61:158–163
- Kim U, Hwang JM. Early stage ethambutol optic neuropathy: retinal nerve fiber layer and optical coherence tomography. Eur J Ophthalmol 2009;19:466–469
- Chai SJ, Foroozan R. Decreased retinal nerve fibre layer thickness detected by optical coherence tomography in patients with ethambutol-induced optic neuropathy. Br J Ophthalmol 2007;91:895–897
- Zoumalan CI, Agarwal M, Sadun AA. Optical coherence tomography can measure axonal loss in patients with ethambutol-induced optic neuropathy. Graefes Arch Clin Exp Ophthalmol 2005;243:410–416
- Chan RY, Kwok AK. Ocular toxicity of ethambutol. Hong Kong Med J 2006;12:56–60
- Fraunfelder FW, Sadun AA, Wood T. Update on ethambutol optic neuropathy. Expert Opin Drug Saf 2006;5:615–618
- Lee EJ, Kim SJ, Choung HK, et al. Incidence and clinical features of ethambutol-induced optic neuropathy in korea. J Neuroophthalmol 2008;28:269–277
- Tsai RK, Lee YH. Reversibility of ethambutol optic neuropathy. J Ocul Pharmacol Ther 1997;13:473–477
- Kumar A, Sandramouli S, Verma L, et al. Ocular ethambutol toxicity: is it reversible? J Clin Neuroophthalmol 1993;13:15–17.
- Menon V, Jain D, Saxena R, Sood R. Prospective evaluation of visual function for early detection of ethambutol toxicity. Br J Ophthalmol 2009;93:1251–1254
- Kim YK, Hwang JM. Serial retinal nerve fiber layer changes in patients with toxic optic neuropathy associated with antituberculosis pharmacotherapy. J Ocul Pharmacol Ther 2009;25:531–535
- Mantyjarvi M, Laitinen T. Normal values for the Pelli–Robson contrast sensitivity test. J Cataract Refract Surg 2001;27:261–266
- Choi SY, Hwang JM. Optic neuropathy associated with ethambutol in Koreans. Korean J Ophthalmol 1997;11:106–110
- Salmon JF, Carmichael TR, Welsh NH. Use of contrast sensitivity measurement in the detection of subclinical ethambutol toxic optic neuropathy. Br J Ophthalmol 1987;71:192–196
- Yiannikas C, Walsh JC, McLeod JG. Visual evoked potentials in the detection of subclinical optic toxic effects secondary to ethambutol. Arch Neurol 1983;40:645648
- Kardon RH, Morrisey MC, Lee AG. Abnormal multifocal electroretinogram (mfERG) in ethambutol toxicity. Semin Ophthalmol 2006;21:215–222
- Hennekes R. Clinical ERG findings in ethambutol intoxication. Graefes Arch Clin Exp Ophthalmol 1982;218:319–321
- Zoumalan CI, Sadun AA. Optical coherence tomography can monitor reversible nerve-fibre layer changes in a patient with ethambutol-induced optic neuropathy. Br J Ophthalmol 2007;91:839–840
- Kim BK, Ahn M. The use of optical coherence tomography in patients with ethambutol-induced optic neuropathy. J Korean Ophthalmol Soc 2010;51:1107–1112
- Yoo YH, Jung KH, Sadun AA, et al. Ethambutol-induced vacuolar changes and neuronal loss in rat retinal cell culture: mediation by endogenous zinc. Toxicol Appl Pharmacol 2000;162:107–114
- Sokol S. Pattern visual evoked potentials: their use in pediatric ophthalmology. Int Ophthalmol Clin 1980;20:251–268
- Oken BS, Chiappa KH, Gill E. Normal temporal variability of the P100. Electroencephalogr Clin Neurophysiol 1987;68:153–156
- Matsuoka Y, Takayanagi T, Sobue I. Experimental ethambutol neuropathy in rats. Morphometric and teased-fiber studies. J Neurol Sci 1981;51:89–99
- Tateishi J, Kuroda S, Otsuki S. Experimental myelo-optico-neuropathy due to ethambutol. Folia Psychiatr Neurol Jpn 1974;28:233–242
- Şahin A, Kürşat Cingü A, Kaya S, et al. The protective effects of caffeic acid phenethyl ester in isoniazid and ethambutol-induced ocular toxicity of rats. Cutan Ocul Toxicol 2013;32:228–233
- Talbert Estlin KA, Sadun AA. Risk factors for ethambutol optic toxicity. Int Ophthalmol 2010;30:63–72
- Budenz DL, Chang RT, Huang X, et al. Reproducibility of retinal nerve fiber thickness measurements using the stratus OCT in normal and glaucomatous eyes. Invest Ophthalmol Vis Sci 2005;46:2440–2443